Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT06208761 |
Other study ID # |
IRB1-050/2566 |
Secondary ID |
|
Status |
Completed |
Phase |
Phase 2
|
First received |
|
Last updated |
|
Start date |
May 9, 2023 |
Est. completion date |
November 6, 2023 |
Study information
Verified date |
January 2024 |
Source |
Burapha University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
One hundred and forty-one male and female participants aged 18-59 years were randomly divided
into 4 groups: 1) control group: neither received exercise program nor supplement but
received placebo capsule for 8 weeks 2) experiment-1: received Triphala capsule at 1,000
mg/day, before breakfast for 500 mg and before dinner for 500 mg, for consecutive 5 days/week
for 8 weeks 3) experiment-2: received leg cycling exercise program in the form of
high-intensity interval training (HIIT) for 28 min/day, 3 days/week for 8 weeks and 4)
experiment-3: received both Triphala capsule and HIIT in the similar extent to the
experiment-1 and experiment-2 groups for 8 weeks. Immune system function and oxidative stress
including blood interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha),
malondialdehyde (MDA), and protein carbonyls levels were analyzed. In addition, blood alanine
aminotransferase (ALT) enzyme and creatinine levels were also analyzed for determining liver
and kidney toxicity, particularly in the Triphala supplementation and combined Triphala
supplementation and HIIT groups.
Description:
This study aimed to investigate and compare immune system function and oxidative stress
before and after supplementation with Triphala and high-intensity interval training in
individuals with post COVID-19. One hundred and forty-one male and female participants aged
18-59 years were randomly divided into 4 groups: 1) control group: neither received exercise
program nor supplement but received placebo capsule for 8 weeks 2) experiment-1: received
Triphala capsule at 1,000 mg/day, before breakfast for 500 mg and before dinner for 500 mg,
for consecutive 5 days/week for 8 weeks 3) experiment-2: received leg cycling exercise
program in the form of high-intensity interval training (HIIT) for 28 min/day, 3 days/week
for 8 weeks and 4) experiment-3: received both Triphala capsule and HIIT in the similar
extent to the experiment-1 and experiment-2 groups for 8 weeks. Immune system function and
oxidative stress including blood interferon-gamma (IFN-gamma), tumor necrosis factor-alpha
(TNF-alpha), malondialdehyde (MDA), and protein carbonyls levels were analyzed. In addition,
blood alanine aminotransferase (ALT) enzyme and creatinine levels were also analyzed for
determining liver and kidney toxicity, particularly in the Triphala supplementation and
combined Triphala supplementation and HIIT groups. Results showed that levels of IFN-gamma,
TNF-alpha, MDA, and protein carbonyls before 8-week program were not different among 4
groups. After the program the levels of IFN-gamma, TNF-alpha, MDA, and protein carbonyls were
significantly decreased in the Triphala supplementation, HIIT, and combined Triphala
supplementation and HIIT groups (all p < 0.05). However, there were no significant
differences between groups. Besides, levels of ALT enzyme and creatinine were not different
among the 4 groups both before and after the 8-week program. There were also no significant
differences between groups. This study concluded that in individuals with post COVID-19,
Triphala supplementation at 1,000 mg/day, 5 days/week for consecutive 8 weeks can improve
immune system function and alleviate oxidative stress. These outcomes are similar to those of
HIIT and combined Triphala supplementation and HIIT interventions. However, prolonged
investigation periods may help observing differences between interventions.